Page last updated: 2024-09-05

enniatin b and Cancer of Cervix

enniatin b has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, W; Dornetshuber-Fleiss, R; Heffeter, P; Heilos, D; Lemmens-Gruber, R; Mohr, T; Novicky, A; Richter, L; Süssmuth, RD; Zlesak, M	1

Other Studies

1 other study(ies) available for enniatin b and Cancer of Cervix

Article	Year
The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo. Biochemical pharmacology, 2015, Feb-01, Volume: 93, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Depsipeptides; Dose-Response Relationship, Drug; Drug Synergism; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, SCID; Niacinamide; Phenylurea Compounds; Sorafenib; T-2 Toxin; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2015

Article

Year

The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo.

Biochemical pharmacology, 2015, Feb-01, Volume: 93, Issue:3

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Depsipeptides; Dose-Response Relationship, Drug; Drug Synergism; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, SCID; Niacinamide; Phenylurea Compounds; Sorafenib; T-2 Toxin; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2015